Effect of Vaitarana Basti and Rasna Guggulu in Sciatica

Phase 3

Completed

• Conditions: Sciatica,

• Registration Number: CTRI/2018/03/012346
• Lead Sponsor: IPGT and RA Gujarat Ayurved university Jamnagar

Brief Summary

This study was a randomized, parallel group, activecontrolled trial comparing the safety and efficacy of *Vaitarana Basti*(16 days) and *Rasna guggulu* 1gms/day (30 days), *Vaitarana basti*(16 days) and *Rasna guggulu* 1 gms/day (30 days) in 101 patients withSciatica that was conducted in Panchakarma Hospital, IPGT&RA, GujaratAyurveda University, Jamnagar. The primary outcome measures were assessed onthe basis of relief found in the cardinal features of the disease. Pain by VisualAnalogue Scale, *Stambha* (stiffness), *Suptata* (numbness), *Spandana*(throbbing/pulsating), *Aruchi* (anorexia), *Tandra* (drowsiness), *Gaurava*(heaviness) muscle power and Straight Leg Raising are the criteria’s which was assessedaccording to their respective standard grading’s before treatment, aftertreatment and after follow up period of 4 weeks.

A total of 101 patients were enrolledfor the study and allotted to three groups by randomization sequence. From thissample 96 patients completed the study and 5 patients discontinued due topersonal reasons. The main findings of the study were: *Vaitarana Basti* is more effective in managing *Vata Kapha*type of *Gridhrasi* while *Rasna guggulu* is better for *Vatika*type of *Gridhrasi*. Upon the assessment on effect of therapies, combinedeffect of *Vaitarana basti* and *Rasna guggulu* provided best resultsin comparison to *Vaitarana Basti* and *Rasna guggulu* givenseparately. *Vaitarana basti* gave better results than *Rasna guggulu*in individual administration of medicines.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-08-03
• Study Completion: 2019-12-12
• Last Update Posted: 2020-09-23

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

• Diagnosed cases of Gridhrasi with symptoms like Ruja, Stambha, Suptata, Spandana, Tandra, Gaurava, Arochaka.
• Patients of age group between 20 and 65 years, belonging to both sex.
• Patients indicated for basti karma Willing to sign the consent for study participation.

Exclusion Criteria

• Uncontrolled diabetes mellitus, hypertension, tuberculosis of spine and hip joint, malignancy of spine or other organs Fracture related to spine Cardiac diseases (ischemic heart disease, coronary artery disease, myocardial infarction etc.) Anemia (hemoglobin % <07.00 mg/dl) Pregnancy.
• Patients contraindicated for basti.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assessment will be done on the basis of special designed proforma	7 days

Secondary Outcome Measures

Name	Time	Method
Assessment will be done on the basis of special designed proforma	60 days

Trial Locations

Locations (1)

IPGT and RA Hospital Jamnagar; 🇮🇳 Jamnagar, GUJARAT, India

IPGT and RA Hospital Jamnagar

🇮🇳Jamnagar, GUJARAT, India

Dr Praveen Kumar K S

Principal investigator

9447506528

drpraveenkumarks@gmail.com